During the past decade, Ospedale Valduce conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 3 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Valduce" #1 sponsor was "Valduce Hospital" with 10 trials, followed by "European Institute of Oncology" with 2 trials sponsored, "Fondazione Italiana Linfomi ONLUS" with 2 trials sponsored, "Mario Negri Institute for Pharmacological Research" with 2 trials sponsored and "University of Milano Bicocca" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Valduce" #1 collaborator was "Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente" with 2 trials as a collaborator, "Gruppo Oncologico Italiano di Ricerca Clinica" with 2 trials as a collaborator, "1Med" with 1 trials as a collaborator, "Aventis Pharmaceuticals" with 1 trials as a collaborator and "Averion International Corporation" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Valduce" are "Colon Cancer" (3 trials), "Acute Renal Colic" (1 trials), "Adenocarcinoma of the Gastroesophageal Junction" (1 trials), "Adenocarcinoma of the Stomach" (1 trials) and "Anticoagulant Disorders" (1 trials). Many other conditions were trialed in "Ospedale Valduce" in a lesser frequency.

Most popular intervention types in "Ospedale Valduce" are "Drug" (16 trials), "Device" (4 trials), "Other" (4 trials), "Diagnostic Test" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (2 trials), "AI" (1 trials), "Bendamustine+Rituximab" (1 trials), "Capsule colonoscopy;" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Valduce" are 27 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ospedale Valduce". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Ospedale Valduce, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Valduce, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".

Ospedale Valduce has several departments that took part in Clinical trials: "Gastroenterology Unit, Valduce Hospital" - 9 trials, "Ospedale Valduce;U.O.S. Oncologia Ed Ematologia" - 3 trials